Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2021-12-07 Declaration of Voting R…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an official communication from DiaSorin S.p.A. dated December 7, 2021, titled 'COMMUNICATION ON TOTAL AMOUNT OF VOTING RIGHTS pursuant to Article 85-bis, paragraph 4-bis, of Consob Regulation no. 11971/1999'. The core subject is the announcement of the total amount of voting rights following an assignment of increased voting rights to a shareholder. This directly relates to shareholder voting structure and rights, which falls under the scope of shareholder meeting information or voting rights announcements. The most specific category available is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it explicitly deals with the total amount of voting rights and changes therein, even if it's not the final result of a vote, but the underlying structure affecting votes. It is not an AGM presentation (AGM-R), a proxy solicitation (PSI), or a general regulatory filing (RNS), as DVA is more precise for this specific content.
2021-12-07 English
Comunicazione ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is an official communication from DiaSorin S.p.A. dated December 7, 2021, titled 'COMUNICAZIONE DELL'AMMONTARE COMPLESSIVO DEI DIRITTI DI VOTO' (Communication of the total amount of voting rights) pursuant to Italian regulation (Regolamento Consob n. 11971/1999). It details a change in the total number of voting rights due to a shareholder acquiring enhanced voting rights (maggiorazione del diritto di voto). This directly relates to the structure and results of shareholder voting rights, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements'. The document explicitly states the updated total voting rights and compares them to the previous situation.
2021-12-07 Italian
DiaSorin business momentum and the Luminex acquisition drive Revenues and Profitability up in the first 9 months of 2021
Earnings Release Classification · 99% confidence The document explicitly states that the Board of Directors of DiaSorin S.p.A. reviewed and approved the '9M 2021 consolidated economic and financial results' on November 11, 2021. It contains detailed financial tables for the '9 months' period (9M 2021) and Q3 2021, including Revenues, EBITDA, EBIT, and Net Profit. This structure and content are characteristic of a comprehensive financial report covering a period shorter than a full year, which aligns with the definition of an Interim/Quarterly Report (IR). Although it is an announcement of results, the document text provided is substantial (nearly 40,000 characters) and contains the full results and commentary, not just a brief announcement of publication (which would suggest RPA or RNS). Therefore, the core content classifies it as an Interim Report. 9M 2021
2021-11-11 English
La crescita del business DiaSorin e l’acquisizione Luminex trainano l’aumento dei Ricavi e della Redditività nei primi 9 mesi del 2021
Earnings Release Classification · 100% confidence The document is a press release from DiaSorin S.p.A. announcing its financial results for the first 9 months of 2021. It contains detailed financial tables (Revenue, EBITDA, EBIT, Net Income) and management commentary on business performance, acquisitions (Luminex), and future guidance. While it is a report of financial results, it is structured as an initial announcement (Earnings Release) rather than a full statutory Annual or Interim Report. It meets the criteria for an Earnings Release (ER) as it provides key highlights and financial data for a specific period. 9M 2021
2021-11-11 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 03/11/2021 - 04/11/2021
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "REPORT ON THE TREASURY SHARES BUY-BACK PLAN OF DIASORIN S.P.A." and details the number of shares purchased, the consideration paid, and the resulting treasury share holding as of November 5, 2021. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing type code for this is POS.
2021-11-05 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 03/11/2021 - 04/11/2021
Transaction in Own Shares Classification · 99% confidence The document is titled "INFORMATIVA SETTIMANALE SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE DI DIASORIN S.P.A." (Weekly Information on the Share Buyback Program of DiaSorin S.p.A.). It details the number of shares purchased, the total consideration, and provides a daily breakdown of these transactions for the period 03/11/2021 to 04/11/2021. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS.
2021-11-05 Italian

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.